Sustained release and standard methylphenidate effects on cognitive and social behavior in children with attention deficit disorder.

Author: BijlsmaJ J, HozaJ, MilichR, MoorerS, PelhamW E, SchmidtC, SturgesJ

Paper Details 
Original Abstract of the Article :
Two studies were conducted to investigate the relative effects of sustained release methylphenidate (Ritalin [SR-20]) and standard methylphenidate (Ritalin, 10 mg, administered twice daily). In the first study, 13 boys with attention deficit disorder participating in a summer treatment program went ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/3658567

データ提供:米国国立医学図書館(NLM)

Methylphenidate: Examining the Effects of Sustained Release and Standard Formulations

This study delves into the world of [attention deficit disorder (ADD)] and examines the relative effects of [sustained release methylphenidate (SR-20)] and [standard methylphenidate] on [cognitive and social behavior] in children with ADD. The researchers conducted two [double-blind, within-subject trials] comparing the effects of both medications to [placebo]. Their findings suggest that both forms of methylphenidate are effective, but there may be differences in their specific effects on different aspects of behavior.

Finding the Right Route Through the Desert of ADD

This research, like a camel caravan navigating a vast and complex desert, explores the different approaches to managing ADD. The authors, like skilled desert guides, carefully examine the potential benefits and drawbacks of different treatment strategies. They find that both SR-20 and standard methylphenidate can be effective, but the specific effects of each medication may vary depending on the individual child and the specific aspect of behavior being targeted.

A Personalized Approach to ADD Treatment

The study's findings underscore the importance of [individualized treatment] for children with ADD. What works for one child may not work for another, and it is crucial to [carefully monitor the effects of medication] and adjust treatment accordingly. This is akin to finding the right path through a vast desert, where the optimal route may vary depending on the specific terrain and the needs of the travelers.

Dr. Camel's Conclusion

This study, like a compass guiding travelers through a complex and challenging desert, offers valuable insights into the nuances of treating ADD with methylphenidate. The research highlights the importance of individualizing treatment, carefully monitoring medication effects, and finding the right approach for each child. This work, like a shimmering oasis in the vast desert of ADD research, provides a vital resource for healthcare professionals and families seeking effective strategies to manage this complex condition.
Date :
  1. Date Completed 1987-11-02
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

3658567

DOI: Digital Object Identifier

3658567

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.